Life Sciences
Below are all our articles under the above category.
Avita Medical (ASX:AVH): Will the FDA’s last minute Christmas present catapult it to new heights in 2025?
Avita Medical (ASX:AVH) received not one, but two Christmas presents from the FDA. On December 19, it announced 510(k) clearance…
Here are our 6 Best ASX Stocks for 2025 and why you should give them a look!
Here are our 6 Best ASX Stocks for 2025! Opthea (ASX:OPT) Its been a long wait, but 2025 will…
Here are 5 ASX biotechs expecting clinical trial results in the next few months!
Here are 5 ASX biotechs expecting clinical trial results in the next few months! Opthea (ASX:OPT) Opthea is developing…
Here’s why Proteomics (ASX:PIQ) shareholders should brace themselves for a big 2025!
Proteomics (ASX:PIQ) is one of the healthcare stocks to watch in CY25, because it has not one, not two, but…
Island Pharmaceuticals’ PROTECT clinical trial is delivering the goods!
Investors were evidently pleased with the results out of Island Pharmaceuticals‘ PROTECT clinical trial…at least if the company’s more than…
Here are 6 ASX CEOs who departed their companies in 2024
Here are 6 ASX CEOs who departed their companies in 2024 Larry Diamond – Zip (ASX:ZIP) Since Afterpay’s acquisition, Zip…
These 2 key milestones awaiting Recce Pharmaceuticals could be very exciting and value accretive!
There are 2 key milestones awaiting Recce Pharmaceuticals (ASX:RCE) in the next few months that investors in this company need…
The $8.8bn Chemist Warehouse Sigma merger is finally going ahead with the ACCC not killing it off
Nearly a year since the $8.8bn Chemist Warehouse Sigma merger was unveiled, it seems we finally got a definitive answer…
Recce’s Phase 2 ABSSSI Clinical Trial is on Track and Producing Outstanding Results
There are encouraging signs from Recce Pharmaceuticals‘ (ASX:RCE) Phase 2 ABSSSI Clinical Trial (Acute Bacterial Skin and Skin Structure Infections).…
PainChek (ASX:PCK): Will 2025 be the year it finally makes progress and enters the US market?
PainChek (ASX:PCK) has among the most admirable medical technologies there is, in the form of an app that can detect…
Imugene (ASX:IMU): This exciting biotech has multiple clinical trial readouts expected in the next 12 months
Imugene (ASX:IMU) is still valued at over $400m, in spite of being valued at over $2bn back in 2021 and…
Here’s why you’ll see more ASX biotechs focus on Asia in the years ahead!
Investors should expect to see more ASX biotechs focus on Asia in the years ahead. And there are good reasons…
Blinklab (ASX:BB1): Is this exciting company the next ResApp?
Blinklab (ASX:BB1), the conclusion to the response to a question of how you could help children with autism – a…
Want to participate in the ASX Schools Sharemarket Game? Here are Some Top Strategies for Success!
The ASX Schools Sharemarket Game is on again! And it is a great way for school students to be introduced…
Here Are The Top 5 Websites for Stock Market News & Analysis in Australia
For Australian investors and traders, staying informed about stock market news is essential for making smart decisions. With a range…
Here are 4 economic indicators that impact stocks and investors must pay attention to
There are several economic indicators that impact stocks, both on the ASX and internationally. Whenever data is released, it can…
As lower interest rates loom, here are 6 ASX stocks that will benefit from forthcoming rate cuts
Here 6 ASX stocks that will benefit from lower interest rates! AGL Energy (ASX:AGL) You might think AGL is…
Here’s why investors fear a US recession, and whether the fears are justified
Investors fear a US recession – there’s no denying it and there’s no other explanation for the market correction in…
Will Ozempic hurt healthcare stocks? Here are 5 reasons we don’t think so
Will Ozempic hurt healthcare stocks? Investors who’ve been selling healthcare stocks left right and centre – except Novo Nordisk of…
ESG Investing in 2024: How can I tell if a stock or fund is ethical or ESG compliant?
ESG investing is becoming increasingly popular with investors. But as this happens, it begs the question as to just how you…
4D Medical (ASX:4DX) could become the next Pro Medicus, it’s a long way to the top
There’s not many Australian radiology companies that seek to conquer the USA, but 4D Medical (ASX:4DX) is one of them.…
Is CSL (ASX:CSL) now facing a more difficult FY24 than investors first thought?
After a decade of nothing but good news for investors in CSL (ASX:CSL), shares fell by ~25% between June and…
Nova Eye Medical (ASX:EYE) has been on a strong run, up 50% in one month. Is there more upside?
Nova Eye Medical (ASX:EYE) has had a good month. The optometry company obtained FDA clearance for its newest generation canaloplasty device…
Why did biotech shares underperform in 2022 and will they rebound with a vengence in 2023?
In the past year, biotech shares have performed poorly. Why has this been the case and will things be better…
Which ASX health stocks might get FDA approval in 2023?
It is the dream of many ASX health stocks and their investors for their company’s device or drug to be…
Immutep (ASX: IMM) has massive potential!
Immutep (ASX: IMM) develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. It has several product candidates at…
Actinogen Medical (ASX: ACW): Good news on phase 2 trials can catapult this stock
Working on a new drug for Alzheimer’s disease Actinogen Medical (ASX: ACW) is a Sydney-based biotechnology company working on finding…
Pfizer delivers the goods on a COVID-19 vaccine
10 November 2020 One of the reasons investors can be optimistic about 2021 is the speed with which the first…